By John Bonifield

CNN Medical Producer

When men show up at the pharmacy to pick up prescription drugs for sex problems, they have several options. Viagra. Cialis. Levitra. That hasn’t been the case for women with similar problems. But a Food and Drug Administration panel next month will debate approving a pill that could bring on the demise of this double standard. The drug, called flibanserin, has been developed to boost women’s libido.

“The most common sexual problem for women is low desire,” says Sheryl Kingsberg, a clinical psychologist with University Hospitals in Cleveland, Ohio. “These women are really distressed by it.”

The German drug company Boehringer Ingelheim developed flibanserin as an antidepressant. The drug didn’t work as a treatment for depression, but it did produce a surprising libido-enhancing side effect in some women.

“There are millions of women who have a sexual life that is problematic for them,” says Michael Sand, the company’s director of clinical research on flibanserin.

According Sand, women taking flibanserin experience an increase in sexual desire and satisfying sexual activity and a decrease in emotional distress.

If the FDA approves flibanserin, Kingsberg says, the drug will be a game changer.

“If nothing else, it's going to open the door to women knowing that they're entitled to good quality sexual health. That it's not just for men anymore,” says Kingsberg, who has been a paid consultant for the company and for other developers of libido-enhancing drugs.

Boehringer Ingelheim plans to discuss its findings on flibanserin with the FDA on June 18.

Next week on CNN, Senior Medical Correspondent Elizabeth Cohen will explore female libido and what’s available now to help restore a lagging sex drive.

Editor's Note: Medical news is a popular but sensitive subject rooted in science. We receive many comments on this blog each day; not all are posted. Our hope is that much will be learned from the sharing of useful information and personal experiences based on the medical and health topics of the blog. We encourage you to focus your comments on those medical and health topics and we appreciate your input. Thank you for your participation.